Blueberrypharmaceuticals

Tykerb 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Tykerb tablets are comes under biological category which is targeted chemotherapy. Tykerb tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu & epidermal growth factor receptor activity 3. Targeted therapy 4. Signal transduction prohibitor PRODUCT DETAILS Brand                    Tykerb Ingredients            Lapatinib Strength                250mg Manufactured       GSK DOSAGE In HER2 positive advanced breast cancer: The recommended dose of Tykerb is 1250mg should be administered orally as a single dose on day 1 to 21repeatedly combined with Capecitabine 2000mg/m2/day (should be taken orally in 2 doses relatively 12 hours apart) on day 1 to 14 in continuous 21 day cycle. Totally 5 tablets of Tykerb should be taken at a time as whole. In hormone receptor positive HER 2 positive advance breast cance

Lapahope 250MG Lapahope 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Lapahope tablets are comes under biological category which is targeted chemotherapy. Lapahope tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu& epidermal growth factor receptor activity 3. Targeted therapy  4. Signal transduction prohibitor MECHANISM OF ACTION Chemically Lapatinib is categorized as 4-anilinoquinazoline derivative, which expels anti-cancer activity by prohibiting intracellular tyrosine kinase domains of EFGR & HER type 2. The ErbB driven tumor cell production has been prohibited by Lapatinib. This growth factor receptor present on cell surface of tumors which may leads to cause cell death. PRODUCT DETAILS Brand                  Lapahope Ingredients          Lapatinib Strength              250mg Manufactured      Natco METABOLISM Lapatinib is a

HERDUO 250MG Herduo 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Herduo tablets are comes under biological category which is targeted chemotherapy. Herduo tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu& epidermal growth factor receptor activity 3. Targeted therapy  4. Signal transduction prohibitor MECHANISM OF ACTION Chemically Lapatinib is categorized as 4-anilinoquinazoline derivative, which expels anti-cancer activity by prohibiting intracellular tyrosine kinase domains of EFGR & HER type 2. The ErbB driven tumor cell production has been prohibited by Lapatinib. This growth factor receptor present on cell surface of tumors which may leads to cause cell death. PRODUCT DETAILS Brand            Herduo Ingredients     Lapatinib Strength            250mg Manufactured    Natco METABOLISM Lapatinib is a substrate of P-g

CRIZALK 250MG DESCRIPTION Crizalk 250mg capsule is used for the therapy of patients with metastatic non-small cell lung cancer. Crizalk 250mg inhibits the anaplastic lymphoma kinase (ALK) and the c-MET/hepatocyte growth factor receptor. This action disturbs certain pathways in the cell, which can inhibit the growth of tumor cells. It is made specifically for the treatment of a type of lung cancer in which ALK is overactive due to an abnormality in the ALK gene. EXCRETION Crizalk is excreted via feces 63% and 22% via urine and half -life is 42 hours PRODUCT DETAILS Brand            Crizalk Ingredients     Crizotinib Strength            250mg Manufactured    Pfizer Ltd CRIZOTINIB SIDE EFFECTS • Infection increased • Breathlessness • Eyesight changes • Bowel changes • Feeling sick • Swelling of hands and feet’s • Decreased appetite • Fatigue • Liver changes • Skin rash • bradycardia STORAGE St

CRIZALK 200MG DESCRIPTION Crizalk 200mg capsule is used for the therapy of patients with metastatic non-small cell lung cancer. Crizalk 200mg belongs to type of tyrosine kinase inhibitor. Kinases are enzymes which are included in many functions, involving cell development and reproduction. MECHANISM OF ACTION More specifically, crizotinib inhibits anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, c-MET), and Recepteurd'OrigineNantais (RON).  Deformity in the ALK gene result by mutations or translocations may causes expression of oncogenic fusion proteins. Certain patients with NSCLC, they have the EML4-ALK gene. PRODUCT DETAILS Brand            Crizalk Ingredients    Crizotinib Strength            200mg Manufactured    Pfizer Ltd CRIZOTINIB SIDE EFFECTS • Infection increased • Breathlessness • Eyesight changes • Bowel changes • Feeling sick • Swelling of hands and feet’s • Decreased appet

GLENZA 40MG Glenza 40mg capsules belongs to nonsteroidal antiandrogen drug which is indicated for use in conjunction with castration to treat metastatic castration-resistant prostate cancer (mCRPC). Glenza capsule is in the form of liquid – filled soft gelatin capsules administer via oral route. Each capsule consists of 40mg enzalutamide in the form of solution in caprylocaproyl polyoxylglycerides. PRODUCT DETAILS Brand Glenza Ingredients Enzalutamide Strength 40mg Manufactured Glenmark Glenza 40mg tablet WHAT GLENZA CAPSULE IS USED FOR Glenza 40mg capsule is an anticancer medication which used for the treatment of patients with metastatic castration resistant prostate cancer. (i.e. surgical treatments that lower testosterone/ prostate cancer that is resistant to medical). ABSORPTION Rapid absorbs from GI tract. Time to peak plasma concentration is 1 hour (range 0.5 to 3 hours). OVER DOSAGE In overdose condition treatment with Glenza 40mg soli